He has experience in quorum sensing-mediated bacterial cell-cell signaling mechanisms at the transcriptional and post-transcriptional level. He has led several drug discovery programs aiming at reducing the impact of antimicrobial resistance through novel anti-virulence target discovery. As part of this work he has experience in the design on bacterial biosensor for high throughput screening of inhibitors of virulence targets.